echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Professor Yimin Zou: The key mechanism of brain synapse degeneration in Alzheimer's disease

    Professor Yimin Zou: The key mechanism of brain synapse degeneration in Alzheimer's disease

    • Last Update: 2021-09-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In brain diseases such as Alzheimer's, these synaptic connections that store our precious memories are known to collapse and disappear prematurely


    Neurobiologists at the University of California San Diego (University of California San Diego) have now discovered the long-sought mechanism for maintaining glutamate synapses


    Despite great efforts, drug discovery for the treatment of Alzheimer's disease has been unsuccessful


    The findings of this study were published in the journal Science Advances on August 18.


    Glutamate synapses are highly polarized structures.


    They were curious about whether these components are related to synaptic degeneration, and tested whether amyloid, a key driver of synapse loss in Alzheimer's disease, affects the function or interaction of these proteins


    "It's like beta amyloid discovered the Achilles heel of our synapses long ago," Professor Zou said


    When the researchers removed Vangl2 from neurons, they found that whether in neuron culture or in animals exposed to amyloid oligomers, beta amyloid no longer caused synaptic degradation


    To further verify the hypothesis that this basic signaling pathway is the main target of synaptic degeneration in Alzheimer's disease, the researchers used 5XFAD mice, a well-known β-amyloid pathological mouse model


    These exciting results indicate that the PCP pathway is the direct target of amyloid-induced synaptic loss in Alzheimer's disease


    "Amyloid pathology and synapse loss usually occur in the early stages of Alzheimer's disease.


    The neuroinflammation reflected by the activation of astrocytes and microglia is also a pathological feature of Alzheimer's disease.


    "This finding may be applicable to general synaptic degeneration, because the PCP component may be the direct synaptic loss that mediates other neurodegenerative diseases (such as Parkinson's disease and Lou Gehrig's disease).


    Journal Reference :

    1. Bo Feng, Andiara E.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.